Aethlon Medical, Inc.
AEMD
$0.58
-$0.02-2.63%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 6.63% | -35.71% | 15.60% | 71.83% | -256.45% |
| Total Depreciation and Amortization | -189.84% | -30.95% | 172.64% | 165.61% | -181.49% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 390.61% | 36,100.00% | -99.86% | -97.09% | 5,418.33% |
| Change in Net Operating Assets | 2.97% | 78.82% | -120.07% | 30.19% | 48.37% |
| Cash from Operations | 6.62% | -13.00% | 3.28% | -2.53% | 16.82% |
| Capital Expenditure | -23.53% | -- | -- | -- | 200.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -23.53% | -- | -- | -- | 200.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -100.00% | 6.97% | -- | -- | -- |
| Repurchase of Common Stock | 16.67% | 63.64% | 38.89% | -86.21% | 59.15% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 80.85% | -- | -- | -- | -- |
| Cash from Financing | -106.59% | -20.27% | 69,379.63% | -100.23% | 33,326.76% |
| Foreign Exchange rate Adjustments | 648.57% | -155.56% | 140.65% | -545.83% | 82.35% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -274.92% | -47.18% | 220.33% | -352.96% | 133.74% |